On Feb. 12, Cephalon
- Revenues increased by 44% to $484.7 million, predominantly because of strong Provigil sales and the launch of Fentora.
- The company estimates first-quarter 2007 revenues to be in the range of $400 million-$410 million and net income to be around $59 million-$66 million.
- Cephalon is a three-star stock in CAPS, the Motley Fool's community-based stock-rating service.
(Figures in millions, except per-share data)
Income Statement Highlights
Q4 2006 |
Q4 2005 |
Change |
|
---|---|---|---|
Sales |
$484.7 |
$336.4 |
44.1% |
Net Profit |
($4.9) |
$18.1 |
N/A |
EPS |
($0.08) |
$0.30 |
N/A |
Diluted Shares |
61.8 |
60.4 |
2.4% |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 |
Q4 2005 |
Change* |
|
---|---|---|---|
Gross Margin |
86.1% |
85.1% |
1.0 |
Operating Margin |
8.8% |
(20.5%) |
29.4 |
Net Margin |
(1.0%) |
5.6% |
(6.6) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Cash + ST Invest. |
$521.7 |
$484.1 |
7.8% |
Accounts Rec. |
$270.0 |
$199.1 |
35.6% |
Inventory |
$174.3 |
$137.9 |
26.4% |
Liabilities |
Q4 2006 |
Q4 2005 |
Change |
---|---|---|---|
Accounts Payable |
$90.6 |
$53.7 |
68.7% |
Long-Term Debt |
$1,248.3 |
$1,696.3 |
(26.4%) |
Learn the ways of the balance sheet.
Cash Flow Highlights
2006 |
2005 |
Change |
|
---|---|---|---|
Cash From Ops. |
$319.9 |
$185.7 |
72.2% |
Capital Expenditures |
$159.9 |
$118.1 |
35.5% |
Free Cash Flow |
$160.0 |
$67.7 |
136.4% |
Find out why Fools always follow the money.
Related Companies:
-
Mylan Laboratories
(NYSE:MYL) -
King Pharmaceuticals
(NYSE:KG) -
Abraxis BioScience
(NASDAQ:ABBI) -
Endo Pharmaceuticals
(NASDAQ:ENDP) -
Shire Pharmaceuticals
(NASDAQ:SHPGY)
Related Foolishness:
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.